Atrion's ROA from the second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Atrion's ROA in the second quarter of 2024?
Atrion Corporation achieved a return on average assets (ROA) of 4.08 % in its second quarter of 2024, which is below Atrion's average return on assets, which stands at 14.57%.

ROA decreased relative to the period ending Mar 31 2024, due to the decline in net income.

However, within the Healthcare sector 135 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2024 from 926 to 1263.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter
Y / Y Total Assets Change	-1.95 %	-1.06 %	93.3 %	-2.22 %	-11.31 %
Y / Y Net Income Change	-93.87 %	-19.89 %	-22.81 %	-66.75 %	-29.79 %
Net Income (TTM) in million	13	19	19	21	27
Return On Assets (TTM)	4.08 %	6.05 %	6.26 %	8.3 %	10.54 %
ATRI's Total Ranking	# 1263	# 926	# 1034	# 610	# 453
Total Assets (TTM) in million	263	261	442	267	268
Seq. Total Assets Change	0.69 %	-40.96 %	65.52 %	-0.35 %	1.6 %
Seq. Net Income Change	-85.6 %	-56.54 %	118.58 %	-55.22 %	88.32 %

ATRI's 5 Years Annual ROA >> Back to ATRI Management Effectiveness >> Compare ATRI ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 39
Sector	# 136
Overall	# 1251

Return On Assets Statistics
High	Average	Low
18.61 %	14.57 %	4.81 %
(Dec 31 2017)		(Jun 30 2024)

Financial Statements
Atrion's Assets	$ 263 million	ATRI's Balance sheet
Atrion's Income	$ 0 million	Quarterly ATRI's Income Statement
ATRI's Income by Division		See ATRI's Income by Division

Annual Return On Assets	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019	(Dec 31 2018) FY 2018
Y / Y Total Assets Change	65.57 %	-33.52 %	53.11 %	13.33 %	13.46 %
Total Assets in million	442	267	401	262	231
Y / Y Net Income Change	-44.55 %	9.01 %	-12.64 %	7.32 %	-6.39 %
Net Income in million	19	35	32	37	34
Annual Return On Assets	4.4 %	13.12 %	8 %	14.03 %	14.82 %

ATRI's 5 Years Annual ROA >> Back to ATRI Management Effectiveness >> Compare ATRI ROA to its Competitors

Comment on ATRI's ROA in the fiscal year ending 2023

In the fiscal year 2023 Atrion's ROA decreased compared to previous year to 4.4 %, due to deterioration of net income -44.55 % to $19.41 million, from $35.01 million a year ago, as ATRI's assets were $441.64 million.

More Return On Assets Ratios
ATRI's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ATRI's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ATRI's Competitors
Subscribers only: Roa for Atrion's Suppliers
Subscribers only: Return On Assets for ATRI's Customers

You may also want to know
ATRI's Roi	ATRI's Inventory Turnover Ratio	ATRI's Growth Rates	ATRI's Dividend Comparisons
	ATRI's Profitability Ratios	ATRI's Asset Turnover Ratio	ATRI's Dividend Growth
ATRI's Roe	ATRI's Valuation Ratios	ATRI's Financial Strength Ratios	ATRI's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2024, within Healthcare Sector	ROA
Arcutis Biotherapeutics Inc	11.04 %
Scienture Holdings Inc	10.97 %
X4 Pharmaceuticals Inc	10.96 %
Amphastar Pharmaceuticals Inc	10.88 %
Electromed Inc	10.78 %
Lemaitre Vascular Inc	10.78 %
Reflect Scientific Inc	10.63 %
Neurocrine Biosciences Inc	10.54 %
Dexcom Inc	10.20 %
Precision Biosciences Inc	10.06 %
Adma Biologics Inc	9.90 %
Relmada Therapeutics Inc	9.31 %
Collegium Pharmaceutical Inc	8.90 %
Stryker Corp	8.81 %
Baxter International Inc	8.79 %
Organon and Co	8.49 %
Progyny Inc	8.43 %
Encompass Health Corporation	8.39 %
Cardiff Lexington Corporation	8.38 %
American Shared Hospital Services	8.09 %
Hologic Inc	7.97 %
Cadre Holdings inc	7.75 %
Abbott Laboratories	7.64 %
Bruker Corporation	7.64 %
Pacific Health Care Organization Inc	7.43 %
Align Technology inc	7.23 %
Revance Therapeutics Inc	7.19 %
National Healthcare Corp	6.96 %
Fonar Corporation	6.81 %
Universal Health Services Inc	6.77 %

Date modified: 2024-09-15T09:08:20+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.